1. Home
  2. ICCC vs VTIX Comparison

ICCC vs VTIX Comparison

Compare ICCC & VTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

SELL

Current Price

$10.32

Market Cap

93.1M

Sector

Health Care

ML Signal

SELL

Logo Virtuix Holdings Inc. Class A Common Stock

VTIX

Virtuix Holdings Inc. Class A Common Stock

BUY

Current Price

$0.52

Market Cap

83.9M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
ICCC
VTIX
Founded
1982
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
83.9M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
ICCC
VTIX
Price
$10.32
$0.52
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $8.50
AVG Volume (30 Days)
6.2K
★ 226.7K
Earning Date
11-12-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
★ 58.99
EPS
★ 0.41
N/A
Revenue
★ $26,493,169.00
$4,252,643.00
Revenue This Year
N/A
$18.40
Revenue Next Year
N/A
$267.43
P/E Ratio
$25.29
★ N/A
Revenue Growth
★ 51.64
18.44
52 Week Low
$4.52
$0.53
52 Week High
$12.10
$9.00

Technical Indicators

Market Signals
Indicator
ICCC
VTIX
Relative Strength Index (RSI) 52.11 21.46
Support Level $9.45 N/A
Resistance Level $10.76 $1.26
Average True Range (ATR) 0.22 0.07
MACD -0.02 -0.01
Stochastic Oscillator 48.80 4.97

Price Performance

Historical Comparison
ICCC
VTIX

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About VTIX Virtuix Holdings Inc. Class A Common Stock

Virtuix Holdings Inc pioneers movement in AI-generated worlds, both imaginary and real. The company is the creator of Omni, a brand of omni-directional treadmills that enable users to walk and run in 360 degrees inside virtual reality (VR) games, digital twins, and other applications. Its technology operates at the intersection of gaming, fitness, and enterprise VR. Its products include Omni Pro, Omni Arena, and Omni One. Its business integrates a consumer and enterprise VR hardware platform anchored by its flagship Omni One product with a defense-oriented simulation system, Virtual Terrain Walk (VTW), targeting next-generation immersive mission planning.

Share on Social Networks: